CAS: 1167985-17-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Ozoralizumab REF: TM-T77126CAS: 1167985-17-2 | SDS-PAGE:> 95%;SEC-HPLC:95.6% | 306,00 €~2.378,00 € | Jue 12 Dic 24 |
 | Ozoralizumab REF: 3D-CLA1283CAS: 1167985-17-2 | - - - | A consultar | Vie 27 Dic 24 |
Ozoralizumab
CAS:1167985-17-2
Ozoralizumab (ATN-103) is a humanized anti-TNFα antibody and a novel TNFα inhibitor.
Pureza:
SDS-PAGE:> 95%;SEC-HPLC:95.6%
Forma y color:
Liquid
Peso molecular:
38.44 kDa
Ref: TM-T77126
| 1mg | 306,00 € | ||
| 5mg | 782,00 € | ||
| 10mg | 1.184,00 € | ||
| 25mg | 1.762,00 € | ||
| 50mg | 2.378,00 € |
Entrega estimada en Estados Unidos, el Jueves 12 de Diciembre de 2024
Ozoralizumab
CAS:1167985-17-2
Trivalent anti-tumour necrosis factor alpha (TNFα) antibody; inflammatory disease treatment
Ref: 3D-CLA1283
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024
